Morphogen-IX
is a drug discovery company that develops bone morphogenetic proteins for the treatment of pulmonary arterial hypertension... Read moreMorphogen-IX
is a drug discovery company that develops bone morphogenetic proteins for the treatment of pulmonary arterial hypertension... Read more
News
Dec 27, 2018
Cambridge Independent
Morphogen-IX: Morphogen-IX: £18.4m boost for PAH medicine
Dec 24, 2018
PharmiWeb
Morphogen-IX: CIC participates in £18.4 million Series B financing for Morphogen-IX
Dec 04, 2018
Cambridge Network
Morphogen-IX: Cambridge spin-out Morphogen-IX announces its clinical development candidate
Nov 27, 2018
Newswire
Press Release: Morphogen-IX : Morphogen-IX Announces MGX292 as Clinical Development Candidate
Jul 09, 2018
Cambridge Network
Morphogen-IX: Morphogen-IX announces appointment of CEO and SAB members
Morphogen-IX Competitors
1
2
3
4
5
6
7
8
9
10